IRD Opus Genetics Inc.
Price (delayed)
$0.9326
Market cap
$42.42M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.15
Enterprise value
$12.1M
Highlights
The revenue is down by 42% year-on-year but it is up by 31% since the previous quarter
IRD's gross profit is down by 42% YoY but it is up by 31% QoQ
The company's net income has shrunk by 112% QoQ
The company's EPS has shrunk by 97% QoQ
Key stats
What are the main financial stats of IRD
Market
Valuations
Earnings
Shares outstanding
45.48M
Market cap
$42.42M
Enterprise value
$12.1M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.38
Price to sales (P/S)
2.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.1
Revenue
$10.99M
Gross profit
$10.99M
Operating income
-$62.07M
Net income
-$57.53M
EBIT
-$57.53M
EBITDA
-$57.52M
Free cash flow
-$25.58M
Per share
Balance sheet
Liquidity
EPS
-$2.15
EPS diluted
-$2.15
Free cash flow per share
-$0.96
Book value per share
$0.21
Revenue per share
$0.41
TBVPS
$1.38
Total assets
$36.86M
Total liabilities
$11.3M
Debt
$0
Equity
$6.72M
Working capital
$25.32M
Debt to equity
0
Current ratio
3.24
Quick ratio
3.2
Net debt/EBITDA
0.53
Margins
Efficiency
Dividend
EBITDA margin
-523.3%
Gross margin
100%
Net margin
-523.4%
Operating margin
-564.7%
Return on assets
-132.3%
Return on equity
-180.2%
Return on invested capital
N/A
Return on capital employed
-225%
Return on sales
-523.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRD stock price
How has the Opus Genetics stock price performed over time
Intraday
2.48%
1 week
-9.46%
1 month
-9.46%
1 year
-57.22%
YTD
-21.63%
QTD
-5.01%
Financial performance
How have Opus Genetics's revenue and profit performed over time
Revenue
$10.99M
Gross profit
$10.99M
Operating income
-$62.07M
Net income
-$57.53M
Gross margin
100%
Net margin
-523.4%
The company's net income has shrunk by 112% QoQ
The operating income has plunged by 111% from the previous quarter
Opus Genetics's net margin has shrunk by 61% QoQ
The operating margin has dropped by 61% since the previous quarter
Growth
What is Opus Genetics's growth rate over time
Valuation
What is Opus Genetics stock price valuation
P/E
N/A
P/B
4.38
P/S
2.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.1
The company's EPS has shrunk by 97% QoQ
The P/B is 94% above the last 4 quarters average of 2.2 and 64% above the 5-year quarterly average of 2.6
Opus Genetics's equity has shrunk by 87% YoY and by 80% QoQ
The revenue is down by 42% year-on-year but it is up by 31% since the previous quarter
IRD's P/S is 26% below its last 4 quarters average of 3.0
Efficiency
How efficient is Opus Genetics business performance
Opus Genetics's return on equity has shrunk by 183% QoQ
IRD's ROA has plunged by 133% from the previous quarter
The company's return on sales has shrunk by 61% QoQ
Dividends
What is IRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRD.
Financial health
How did Opus Genetics financials performed over time
The total liabilities has surged by 179% year-on-year and by 85% since the previous quarter
The current ratio has dropped by 76% year-on-year and by 51% since the previous quarter
Opus Genetics's debt is 100% lower than its equity
Opus Genetics's equity has shrunk by 87% YoY and by 80% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.